Skip to main content

Welcome to Wool.com

An innovation hub for the woolgrowers of Australia

You may also be interested in

06.12.2019 Source: AWEX
AWEX EMI 1492
Micron 17 1914 -54
Micron 18 1798 -51
Micron 19 1712 -31
Micron 20 1674 -26
Micron 21 1671 -29
Micron 22 1664n -70
Micron 26 1133n -28
Micron 28 835 -10
Micron 30 684n -10
Micron 32 435n -25
MCar 1077 -2
Welfare Improved Practices
Welfare-improved surgery with pain relief is rapidly replacing the practice of traditional mulesing without pain relief.

Strong progress is being made and a significant proportion of woolgrowers have removed the need for the traditional mulesing procedure in some or all of their sheep.

In a 2017 survey of 1,200 merino breeders across Australia, the results showed that 83% of Merino lambs mulesed received pain relief.

Recent major developments in welfare-improved practises

Tri-Solfen is a topical product applied after mulesing and contains local anaesthetic agents to alleviate pain, and haemostatic and antiseptic agents to reduce bleeding and promote healing.

In the six and a half years since Tri-Solfen was first registered, it has become widely used – three-quarters of Merinos mulesed now receive pain relief.

Ilium Buccalgesic® OTM, a buccal formulation containing the non-steroidal anti-inflammatory drug (NSAID) meloxicam, was registered in 2016 for the alleviation of pain associated with castration and tail docking in sheep and in October 2017 the Australian Pesticides and Veterinary Medicines Authority (APVMA) approved Buccalgesic for the alleviation of pain associated with mulesing.

Numnuts is a handheld device that includes an easy-to-use banding tool providing fast ring application, plus an operator-safe two-stage injection mechanism that ensures the correct dose of pain relief is dispensed to the right location. The patented technology is scientifically proven to reduce tail docking and castration pain by up to 68%.

A recently concluded research project – co-funded by AWI, CSIRO and Troy Laboratories Pty Ltd – provides a welfare assessment of Tri-Solfen® and the Meloxicam-based Ilium Buccalgesic® OTM product, on female lambs for mulesing.

The best outcome was seen where Tri-Solfen and Buccalgesic were used in combination, delivering the benefits of both local anaesthetic and non-steroidal anti-inflammatory agents. Buccalgesic therefore offers a good adjunct to Tri-Solfen in extending the pain relief period for sheep undergoing surgical mulesing.

- CSIRO Principal Research Scientist, Alison Small
Articles That Might Interest You
Progress
An overview of the approach taken by AWI to tackle breech flystrike. Read more
Breeding for Breech Strike Resistance
Why breeding for breech strike resistance is the long term sustainable solution. Read more
Breech Flystrike Prevention Tools
Research and development in fly genome sequencing, nanotechnology and vaccine technologies. Read more